Skip to main content
NIH funding notice RFA-DE-15-002

Next-Gen Rapid Testing and Point-of-Care Diagnosis for Oral Pathogens (R43/R44)

Closed on November 20, 2014.

Posted
July 1, 2014
Close date
November 20, 2014
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
4
4 new
Median first-year cost
$219,001
$875,061 in all
Institutions
4
4 contact PIs
Patents
1
from 1 funded project

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. IMMPORT THERAPEUTICS, INC.1
  2. INNOVATIVE DIAGNOSTICS, INC.1
  3. INSILIXA, INC.1
  4. JAN BIOTECH, INC.1

Most frequent study sections

  1. Special Emphasis Panel (ZDE1 JR (11))4
4 awards under RFA-DE-15-002 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2015Point of Care Detection of Oral Pathogens1R43DE025440-01Camerini, DavidIMMPORT THERAPEUTICS, INC., CAFirst-year cost $225,000Study section ZDE1
FY2015Developing a POC CMOS biochip for oral HPV detection and quantification1R43DE025441-01Hassibi, ArjangINSILIXA, INC., CAFirst-year cost $224,764Study section ZDE1
FY2015Point-of-Care Spliced RNA Diagnostic for Oral Detection of Replication-Competent Latent HIV-1 Infection1R43DE025437-01Huie, Janet LJAN BIOTECH, INC., NYFirst-year cost $213,238Study section ZDE1
FY2015Development and Feasibility of PerioDX for Identification of Periodontal Disease1R43DE025431-01Novak, Michael JohnINNOVATIVE DIAGNOSTICS, INC., KYFirst-year cost $212,059Study section ZDE1
Newest fiscal year first, then first-year cost.

Patents from its funded projects

1 patent names 1 of the 4 funded projects.

  1. US 10,400,274 (opens the patent at USPTO, a PDF, in a new tab)Fluorogenic Probes and Their Use in Quantitative Detection of Target RNA SequencesGranted September 3, 2019 to Jan Biotech, Inc.R43DE025437 · JAN BIOTECH, INC., NY

Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.

Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.